|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021745,
umls-concept:C0023828,
umls-concept:C0026473,
umls-concept:C0086418,
umls-concept:C0205195,
umls-concept:C0332256,
umls-concept:C0443224,
umls-concept:C0596402,
umls-concept:C1280500,
umls-concept:C1510986,
umls-concept:C1515895,
umls-concept:C1533691
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1995-3-2
|
|
pubmed:abstractText |
The purpose of the present study was to investigate whether human recombinant interferon-gamma (hrIFN-gamma) can act synergically with various activators in increasing the cytotoxicity of cancer patient monocytes against fresh autologous and allogeneic tumor cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
31
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
385-91
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7839471-Acetylmuramyl-Alanyl-Isoglutamine,
pubmed-meshheading:7839471-Cytotoxicity, Immunologic,
pubmed-meshheading:7839471-Drug Carriers,
pubmed-meshheading:7839471-Drug Synergism,
pubmed-meshheading:7839471-Humans,
pubmed-meshheading:7839471-Interferon-gamma,
pubmed-meshheading:7839471-Liposomes,
pubmed-meshheading:7839471-Monocytes,
pubmed-meshheading:7839471-Phosphatidylethanolamines,
pubmed-meshheading:7839471-Recombinant Proteins,
pubmed-meshheading:7839471-Reference Values,
pubmed-meshheading:7839471-Tumor Cells, Cultured
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide on human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells.
|
|
pubmed:affiliation |
Divisione di Oncologia Medica, Centro di Riferimento Oncologico, Aviano (PN), Italy.
|
|
pubmed:publicationType |
Journal Article
|
